Globus Medical, Inc.
GMED
$58.74
-$0.88-1.48%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 776.83% | 178.51% | -16.19% | -42.05% | -80.09% |
| Total Depreciation and Amortization | 19.43% | 45.65% | 75.75% | 184.38% | 222.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -87.29% | 81.72% | 182.01% | 483.41% | 621.63% |
| Change in Net Operating Assets | 107.30% | 67.27% | 16.33% | -97.70% | -75.90% |
| Cash from Operations | 155.60% | 166.13% | 113.82% | 104.62% | 41.33% |
| Capital Expenditure | -40.63% | -35.35% | -47.47% | -64.38% | -57.02% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 18.74% | 98.37% | 94.04% | 94.60% | -844.36% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -81.91% | -79.78% | -106.35% | 20.39% | 1,518.76% |
| Cash from Investing | -256.91% | -99.22% | -158.11% | 418.29% | 402.74% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 394.35% | 979.80% | 790.85% | 57.18% | -42.80% |
| Repurchase of Common Stock | 32.65% | 39.48% | 60.83% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 48.42% | 47.99% | -467.47% | -401.40% | -394.73% |
| Cash from Financing | -69.46% | -56.18% | 88.05% | -1,805.35% | -1,214.00% |
| Foreign Exchange rate Adjustments | 691.99% | 742.50% | -88.30% | 147.99% | 4,653.19% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -274.06% | -21.39% | 0.10% | 136.01% | -33.21% |